{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:37:33Z","timestamp":1792805853052,"version":"4.5.0"},"reference-count":131,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T00:00:00Z","timestamp":1597881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","award":["TA-GT-0715-0665-LUMC"],"award-info":[{"award-number":["TA-GT-0715-0665-LUMC"]}],"id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010372","name":"Rotterdamse Stichting Blindenbelangen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010372","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010318","name":"Landelijke Stichting voor Blinden en Slechtzienden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010374","name":"Stichting Blindenhulp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010321","name":"Oogfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2020.00838","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T04:32:55Z","timestamp":1597897975000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Novel Therapeutic Approaches for the Treatment of Retinal Degenerative Diseases: Focus on CRISPR\/Cas-Based Gene Editing"],"prefix":"10.3389","volume":"14","author":[{"given":"Carmen","family":"Gallego","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel A. F. V.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Wijnholds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,8,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3283","DOI":"10.1182\/blood-2013-04-497354","article-title":"Robust ZFN-mediated genome editing in adult hemophilic mice.","volume":"122","author":"Anguela","year":"2013","journal-title":"Blood"},{"key":"B2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA.","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1089\/jop.2018.0087","article-title":"Gene therapy for inherited retinal degeneration.","volume":"35","author":"Arbabi","year":"2019","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"B4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41556-020-0472-5","article-title":"Fast and efficient generation of knock-in human organoids using homology-independent CRISPR\u2013Cas9 precision genome editing.","volume":"22","author":"Artegiani","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/mt.2015.220","article-title":"In vivo CRISPR\/Cas9 gene editing corrects retinal dystrophy in the S334ter-3 rat model of autosomal dominant retinitis pigmentosa.","volume":"24","author":"Bakondi","year":"2016","journal-title":"Mol. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.ymthe.2020.01.023","article-title":"Repair of retinal degeneration following ex vivo minicircle DNA gene therapy and transplantation of corrected photoreceptor progenitors.","volume":"28","author":"Barnea-Cramer","year":"2020","journal-title":"Mol. Ther."},{"key":"B7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.molcel.2014.03.011","article-title":"CRISPR-cas systems: prokaryotes upgrade to adaptive immunity.","volume":"54","author":"Barrangou","year":"2014","journal-title":"Mol. Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B Viruses and Adenoviruses 2 and 5.","volume":"275","author":"Bergelson","year":"1997","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.preteyeres.2010.03.004","article-title":"The molecular basis of human retinal and vitreoretinal diseases.","volume":"29","author":"Berger","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"B10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ajo.2016.07.013","article-title":"Long-term follow-up of patients with retinitis pigmentosa receiving intraocular ciliary neurotrophic factor implants.","volume":"170","author":"Birch","year":"2016","journal-title":"Am. J. Ophthalmol."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040869","article-title":"High-capacity adenoviral vectors permit robust and versatile testing of DMD gene repair tools and strategies in human cells.","volume":"9","author":"Brescia","year":"2020","journal-title":"Cells"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2019.100789","article-title":"Sharpening the molecular scissors?: advances in gene-editing technology.","volume":"23","author":"Broeders","year":"2020","journal-title":"iScience"},{"key":"B13","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s41592-019-0508-6","article-title":"Multiplexed genome engineering by Cas12a and CRISPR arrays encoded on single transcripts.","volume":"16","author":"Campa","year":"2019","journal-title":"Nat. Methods"},{"key":"B14","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.tcb.2015.07.009","article-title":"Repair pathway choices and consequences at the double-strand break.","volume":"26","author":"Ceccaldi","year":"2016","journal-title":"Trends Cell Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1016\/j.ymthe.2017.07.011","article-title":"A new promoter allows optogenetic vision restoration with enhanced sensitivity in macaque retina.","volume":"25","author":"Chaffiol","year":"2017","journal-title":"Mol. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.jmb.2015.10.014","article-title":"Origins of programmable nucleases for genome engineering.","volume":"428","author":"Chandrasegaran","year":"2016","journal-title":"J. Mol. Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","article-title":"Identification of preexisting adaptive immunity to Cas9 proteins in humans.","volume":"25","author":"Charlesworth","year":"2019","journal-title":"Nat. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s41565-019-0539-2","article-title":"A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing.","volume":"14","author":"Chen","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1038\/mt.2008.211","article-title":"Persistent expression of PEDF in the eye using high-capacity adenovectors.","volume":"16","author":"Chen","year":"2008","journal-title":"Mol. Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/mt.2015.164","article-title":"Engineered viruses as genome editing devices.","volume":"24","author":"Chen","year":"2016","journal-title":"Mol. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.isci.2018.08.001","article-title":"DNA, RNA, and protein tools for editing the genetic information in human cells.","volume":"6","author":"Chen","year":"2018","journal-title":"iScience"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00687-1","article-title":"In trans paired nicking triggers seamless genome editing without double-stranded DNA cutting.","volume":"8","author":"Chen","year":"2017","journal-title":"Nat. Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/nar\/gkz1121","article-title":"Expanding the editable genome and CRISPR-Cas9 versatility using DNA cutting-free gene targeting based on in trans paired nicking.","volume":"48","author":"Chen","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nbt.2507","article-title":"Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease.","volume":"31","author":"Cho","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"B25","first-page":"48","article-title":"A method for gene knockdown in the retina using a lipid-based carrier.","volume":"26","author":"Chu-Tan","year":"2020","journal-title":"Mol. Vis."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2012.3","article-title":"Antisense oligonucleotide (AON)-based therapy for leber congenital amaurosis caused by a frequent mutation in CEP290.","volume":"1","author":"Collin","year":"2012","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems.","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/genes9040215","article-title":"Special issue introduction: inherited retinal disease: novel candidate genes, genotype\u2013phenotype correlations, and inheritance models.","volume":"9","author":"Cremers","year":"2018","journal-title":"Genes"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05843-9","article-title":"Cas9 immunity creates challenges for CRISPR gene editing therapies.","volume":"9","author":"Crudele","year":"2018","journal-title":"Nat. Commun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nbt.4114","article-title":"Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration.","volume":"36","author":"Da Cruz","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.cell.2015.03.028","article-title":"Efficient intracellular delivery of native proteins.","volume":"161","author":"D\u2019Astolfo","year":"2015","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2017.10.004","article-title":"Molecular genetics and emerging therapies for retinitis pigmentosa: basic research and clinical perspectives.","volume":"63","author":"Dias","year":"2018","journal-title":"Prog. Retin. Eye Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1172\/JCI120429","article-title":"Gene therapy and genome surgery in the retina.","volume":"128","author":"DiCarlo","year":"2018","journal-title":"J. Clin. Invest."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1126\/science.1258096","article-title":"The new frontier of genome engineering with CRISPR-Cas9.","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2019.08.018","article-title":"How long does gene therapy last? 4-year follow-up of phase 3 voretigene neparvovec trial in RPE65-associated LCA\/inherited retinal disease.","volume":"23","author":"Drack","year":"2019","journal-title":"J. Am. Assoc. Pediatr. Ophthalmol. Strabismus"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-17180-w","article-title":"CRISPR\/Cas9 delivery with one single adenoviral vector devoid of all viral genes.","volume":"7","author":"Ehrke-Schulz","year":"2017","journal-title":"Sci. Rep."},{"key":"B37","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.stemcr.2018.07.005","article-title":"Characterization and transplantation of CD73-positive photoreceptors isolated from human iPSC-derived retinal organoids.","volume":"11","author":"Gagliardi","year":"2018","journal-title":"Stem Cell Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1002\/1873-3468.13691","article-title":"State-of-the-art human adenovirus vectorology for therapeutic approaches.","volume":"593","author":"Gao","year":"2019","journal-title":"FEBS Lett."},{"key":"B39","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nbt.3900","article-title":"Engineered Cpf1 variants with altered PAM specificities.","volume":"35","author":"Gao","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00789","article-title":"Optogenetic light sensors in human retinal organoids.","volume":"12","author":"Garita-Hernandez","year":"2018","journal-title":"Front. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12330-2","article-title":"Restoration of visual function by transplantation of optogenetically engineered photoreceptors.","volume":"10","author":"Garita-Hernandez","year":"2019","journal-title":"Nat. Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"E2579","DOI":"10.1073\/pnas.1208507109","article-title":"Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria.","volume":"109","author":"Gasiunas","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B43","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of AT to GC in genomic DNA without DNA cleavage.","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/rmv.494","article-title":"Adenovirus: from foe to friend.","volume":"16","author":"Gon\u00e7alves","year":"2006","journal-title":"Rev. Med. Virol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/d41573-018-00016-1","article-title":"Gene therapies in ophthalmic disease.","volume":"18","author":"Gordon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1101\/gad.7.12a.2298","article-title":"Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice.","volume":"7","author":"Grompe","year":"1993","journal-title":"Genes Dev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/s41587-020-0535-y","article-title":"A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing.","volume":"38","author":"Gr\u00fcnewald","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1073\/pnas.1913179117","article-title":"Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases.","volume":"117","author":"Hanany","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12449-2","article-title":"High levels of AAV vector integration into CRISPR-induced DNA breaks.","volume":"10","author":"Hanlon","year":"2019","journal-title":"Nat. Commun."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.drudis.2019.03.004","article-title":"Drug delivery to retinal photoreceptors.","volume":"24","author":"Himawan","year":"2019","journal-title":"Drug Discov. Today"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/nmeth.3075","article-title":"Adenoviral vector DNA for accurate genome editing with engineered nucleases.","volume":"11","author":"Holkers","year":"2014","journal-title":"Nat. Methods"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/vision1030022","article-title":"Inherited retinal disease therapies targeting precursor messenger ribonucleic acid.","volume":"1","author":"Huang","year":"2017","journal-title":"Vision"},{"key":"B53","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1167\/iovs.16-19316","article-title":"AAV-mediated CRISPR\/Cas gene editing of retinal cells in Vivo.","volume":"57","author":"Hung","year":"2016","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.celrep.2019.12.064","article-title":"Tandem paired nicking promotes precise genome editing with scarce interference by p53.","volume":"30","author":"Hyodo","year":"2020","journal-title":"Cell Rep."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1128\/JB.00580-17","article-title":"History of CRISPR-Cas from encounter with a mysterious repeated sequence to genome editing technology.","volume":"200","author":"Ishino","year":"2018","journal-title":"J. Bacteriol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.dnarep.2013.04.015","article-title":"DNA repair mechanisms in dividing and non-dividing cells.","volume":"12","author":"Iyama","year":"2013","journal-title":"DNA Repair"},{"key":"B57","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.00471","article-title":"RNA-programmed genome editing in human cells.","volume":"2","author":"Jinek","year":"2013","journal-title":"eLife"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.5966\/sctm.2013-0013","article-title":"Genetically modified neural stem cells for a local and sustained delivery of neuroprotective factors to the dystrophic mouse retina.","volume":"2","author":"Jung","year":"2013","journal-title":"Stem Cells Transl. Med."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21020522","article-title":"Degenerated cones in cultured human retinas can successfully be optogenetically reactivated.","volume":"21","author":"Kamar","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-8669-9_1","article-title":"Identification and analysis of genes associated with inherited retinal diseases","author":"Khan","year":"2019","journal-title":"Methods in Molecular Biology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1101\/gr.219089.116","article-title":"Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration.","volume":"27","author":"Kim","year":"2017","journal-title":"Genome Res."},{"key":"B63","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1101\/gr.231936.117","article-title":"CRISPR RNAs trigger innate immune responses in human cells.","volume":"28","author":"Kim","year":"2018","journal-title":"Genome Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.","volume":"529","author":"Kleinstiver","year":"","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nbt.3620","article-title":"Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells.","volume":"34","author":"Kleinstiver","year":"","journal-title":"Nat. Biotechnol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"key":"B67","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.preteyeres.2008.03.001","article-title":"Molecular chaperones and photoreceptor function.","volume":"27","author":"Kosmaoglou","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"B68","first-page":"1965","article-title":"Long-term transgene expression in the RPE after gene transfer with a high-capacity adenoviral vector.","volume":"43","author":"Kreppel","year":"2002","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2019.05.011","article-title":"Mesenchymal stem cells provide paracrine neuroprotective resources that delay degeneration of co-cultured organotypic neuroretinal cultures.","volume":"185","author":"Labrador-Velandia","year":"2019","journal-title":"Exp. Eye Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.stem.2008.10.015","article-title":"Transplantation of human embryonic stem cell-derived photoreceptors restores some visual function in Crx-deficient mice.","volume":"4","author":"Lamba","year":"2009","journal-title":"Cell Stem Cell"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20163896","article-title":"Causative links between protein aggregation and oxidative stress: A review.","volume":"20","author":"L\u00e9vy","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B72","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","article-title":"Engineering adeno-associated virus vectors for gene therapy.","volume":"21","author":"Li","year":"2020","journal-title":"Nat. Rev. Genet."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03396-8","article-title":"Cas12a mediates efficient and precise endogenous gene tagging via MITI: microhomology-dependent targeted integrations.","author":"Li","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41434-020-0134-z","article-title":"Nr2e3 is a genetic modifier that rescues retinal degeneration and promotes homeostasis in multiple models of retinitis pigmentosa.","author":"Li","year":"2020","journal-title":"Gene Ther."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1080\/10717544.2018.1474964","article-title":"Delivering CRISPR: a review of the challenges and approaches.","volume":"25","author":"Lino","year":"2018","journal-title":"Drug Deliv."},{"key":"B76","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/s41591-018-0327-9","article-title":"Development of a gene-editing approach to restore vision loss in Leber congenital amaurosis type 10.","volume":"25","author":"Maeder","year":"2019","journal-title":"Nat. Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","article-title":"RNA-guided human genome engineering via Cas9.","volume":"339","author":"Mali","year":"2013","journal-title":"Science"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1167\/iovs.03-0730","article-title":"Efficient gene transfer into retinal cells using adenoviral vectors: dependence on receptor expression.","volume":"45","author":"Mallam","year":"2004","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"B79","first-page":"611","article-title":"Adeno-associated virus (AAV) dual vector strategies for gene therapy encoding large transgenes.","volume":"90","author":"McClements","year":"2017","journal-title":"Yale J. Biol. Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.tig.2008.08.007","article-title":"MMEJ repair of double-strand breaks (director\u2019s cut): deleted sequences and alternative endings.","volume":"24","author":"McVey","year":"2008","journal-title":"Trends Genet."},{"key":"B81","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.xphs.2019.10.003","article-title":"Immunogenicity of Cas9 Protein.","volume":"109","author":"Mehta","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"B82","doi-asserted-by":"publisher","first-page":"R58","DOI":"10.1093\/hmg\/ddx180","article-title":"Genetic modifiers as relevant biological variables of eye disorders.","volume":"26","author":"Meyer","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"B83","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/14712598.2018.1389886","article-title":"Gene therapy for inherited retinal and optic nerve degenerations.","volume":"18","author":"Moore","year":"2018","journal-title":"Expert Opin. Biol. Ther."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6560","article-title":"Microhomology-mediated end-joining-dependent integration of donor DNA in cells and animals using TALENs and CRISPR\/Cas9.","volume":"5","author":"Nakade","year":"2014","journal-title":"Nat. Commun."},{"key":"B85","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1080\/21655979.2017.1282018","article-title":"Cas9, Cpf1 and C2c1\/2\/3\u2014What\u2019s next?","volume":"8","author":"Nakade","year":"2017","journal-title":"Bioengineered"},{"key":"B86","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1101\/gr.226027.117","article-title":"Precise and efficient nucleotide substitution near genomic nick via noncanonical homology-directed repair.","volume":"28","author":"Nakajima","year":"2018","journal-title":"Genome Res."},{"key":"B87","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.tibtech.2018.03.004","article-title":"Strategies for in vivo genome editing in nondividing cells.","volume":"36","author":"Nami","year":"2018","journal-title":"Trends Biotechnol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41591-019-0344-3","article-title":"Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy.","volume":"25","author":"Nelson","year":"2019","journal-title":"Nat. Med."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf8729","article-title":"Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems.","volume":"353","author":"Nishida","year":"2016","journal-title":"Science"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21041380","article-title":"Using transcriptomic analysis to assess double-strand break repair activity: towards precise in vivo genome editing.","volume":"21","author":"Pasquini","year":"2020","journal-title":"Int. J. Mol. Sci"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1186\/s12868-018-0411-6","article-title":"Optogenetic regulation of transcription.","volume":"19","author":"Polesskaya","year":"2018","journal-title":"BMC Neurosci."},{"key":"B92","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In vivo genome editing using Staphylococcus aureus Cas9.","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ejcb.2011.01.006","article-title":"New insights into stability of recombinant adenovirus vector genomes in mammalian cells.","volume":"91","author":"Rauschhuber","year":"2012","journal-title":"Eur. J. Cell Biol."},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15790","article-title":"Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery.","volume":"8","author":"Rees","year":"2017","journal-title":"Nat. Commun."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/stem.2586","article-title":"Generation of storable retinal organoids and retinal pigmented epithelium from adherent human iPS cells in xeno-free and feeder-free conditions.","volume":"35","author":"Reichman","year":"2017","journal-title":"Stem Cells"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103643","article-title":"High-capacity adenoviral vectors: expanding the scope of gene therapy.","volume":"21","author":"Ricobaraza","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B97","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ymthe.2016.12.006","article-title":"CRISPR\/Cas9-mediated genome editing as a therapeutic approach for Leber Congenital Amaurosis 10.","volume":"25","author":"Ruan","year":"2017","journal-title":"Mol. Ther."},{"key":"B98","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(17)31868-8","article-title":"Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.","volume":"390","author":"Russell","year":"2017","journal-title":"Lancet"},{"key":"B99","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nprot.2015.140","article-title":"MMEJ-Assisted gene knock-in using TALENs and CRISPR-Cas9 with the PITCh systems.","volume":"11","author":"Sakuma","year":"2016","journal-title":"Nat. Protoc."},{"key":"B100","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.omtm.2019.11.016","article-title":"Genome editing in patient iPSCs corrects the most prevalent USH2A mutations and reveals intriguing mutant mRNA expression profiles.","volume":"17","author":"Sanjurjo-Soriano","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5056279","article-title":"Guiding lights in genome editing for inherited retinal disorders: implications for gene and cell therapy.","volume":"2018","author":"Sanjurjo-Soriano","year":"2018","journal-title":"Neural Plast."},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12338","article-title":"CRISPaint allows modular base-specific gene tagging using a ligase-4-dependent mechanism.","volume":"7","author":"Schmid-Burgk","year":"2016","journal-title":"Nat. Commun."},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf2838","article-title":"Emerging therapies for inherited retinal degeneration.","volume":"8","author":"Scholl","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"B104","doi-asserted-by":"publisher","first-page":"E81","DOI":"10.1073\/pnas.1512590113","article-title":"Transplantation of human embryonic stem cell-derived retinal tissue in two primate models of retinal degeneration.","volume":"113","author":"Shirai","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B105","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1073\/pnas.0600236103","article-title":"Ciliary neurotrophic factor (CNTF) for human retinal degeneration: Phase I trial of CNTF delivered by encapsulated cell intraocular implants.","volume":"103","author":"Sieving","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B106","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.exer.2018.09.003","article-title":"Optogenetic approaches to vision restoration.","volume":"178","author":"Simunovic","year":"2019","journal-title":"Exp. Eye Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.aad5227","article-title":"Rationally engineered Cas9 nucleases with improved specificity.","volume":"351","author":"Slaymaker","year":"2016","journal-title":"Science"},{"key":"B108","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/978-3-030-27378-1_43","article-title":"Cham","author":"Sundaramurthi","year":"2019","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"B109","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s10038-017-0352-4","article-title":"In vivo genome editing via the HITI method as a tool for gene therapy.","volume":"63","author":"Suzuki","year":"2018","journal-title":"J. Hum. Genet."},{"key":"B110","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nature20565","article-title":"In vivo genome editing via CRISPR\/Cas9 mediated homology-independent targeted integration.","volume":"540","author":"Suzuki","year":"2016","journal-title":"Nature"},{"key":"B111","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1167\/iovs.09-4367","article-title":"Adenovirus vectors targeting distinct cell types in the retina.","volume":"51","author":"Sweigard","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"B112","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1080\/13816810.2018.1495745","article-title":"Gene therapy in inherited retinal degenerative diseases, a review.","volume":"39","author":"Takahashi","year":"2018","journal-title":"Ophthalmic Genet."},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040953","article-title":"Adenoviral vectors meet gene editing: a rising partnership for the genomic engineering of human stem cells and their progeny.","volume":"9","author":"Tasca","year":"2020","journal-title":"Cells"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3390\/genes10060453","article-title":"The cGMP pathway and inherited photoreceptor degeneration: targets, compounds, and biomarkers.","volume":"10","author":"Tolone","year":"2019","journal-title":"Genes"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0855-8","article-title":"Oxidative stress and autophagy-related changes during retinal degeneration and development.","volume":"9","author":"Trachsel-Moncho","year":"2018","journal-title":"Cell Death Dis."},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3390\/genes10040287","article-title":"Adeno-associated viral vectors as a tool for large gene delivery to the retina.","volume":"10","author":"Trapani","year":"2019","journal-title":"Genes"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3390\/genes10090654","article-title":"Molecular therapies for inherited retinal diseases\u2014current standing, opportunities and challenges.","volume":"10","author":"V\u00e1zquez-Dom\u00ednguez","year":"2019","journal-title":"Genes"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003040","article-title":"CNOT3 is a modifier of PRPF31 mutations in retinitis pigmentosa with incomplete penetrance.","volume":"8","author":"Venturini","year":"2012","journal-title":"PLoS Genet."},{"key":"B119","doi-asserted-by":"publisher","first-page":"E2997","DOI":"10.1073\/pnas.1718792115","article-title":"Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration.","volume":"115","author":"Vighi","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B120","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-associated virus vector as a platform for gene therapy delivery.","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"B121","doi-asserted-by":"publisher","first-page":"E3764","DOI":"10.1073\/pnas.1521749113","article-title":"Activation of the molecular chaperone, sigma 1 receptor, preserves cone function in a murine model of inherited retinal degeneration.","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-1304-1","article-title":"The effect of human gene therapy for RPE65-associated Leber\u2019s congenital amaurosis on visual function: a systematic review and meta-analysis.","volume":"15","author":"Wang","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.53968","article-title":"Efficient targeted integration directed by short homology in zebrafish and mammalian cells.","volume":"9","author":"Wierson","year":"2020","journal-title":"eLife"},{"key":"B124","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.omtn.2018.10.015","article-title":"Overcoming the Undesirable CRISPR-Cas9 expression in gene correction.","volume":"13","author":"Xia","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1186\/s13036-019-0217-9","article-title":"HMEJ-mediated efficient site-specific gene integration in chicken cells.","volume":"13","author":"Xie","year":"2019","journal-title":"J. Biol. Eng."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2016.09.001","article-title":"In vivo genome editing as a potential treatment strategy for inherited retinal dystrophies.","volume":"56","author":"Yanik","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"B127","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/cr.2017.76","article-title":"Homology-mediated end joining-based targeted integration using CRISPR\/Cas9.","volume":"27","author":"Yao","year":"2017","journal-title":"Cell Res."},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3791\/56844","article-title":"CRISPR\/Cas9-mediated targeted integration in vivo using a homology-mediated end joining-based strategy.","volume":"133","author":"Yao","year":"2018","journal-title":"J. Vis. Exp."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1038\/s41556-019-0425-z","article-title":"Advances in genome editing through control of DNA repair pathways.","volume":"21","author":"Yeh","year":"2019","journal-title":"Nat. Cell Biol."},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2018.00053","article-title":"In vivo applications of CRISPR-based genome editing in the retina.","volume":"6","author":"Yu","year":"2018","journal-title":"Front. Cell Dev. Biol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cell.2015.09.038","article-title":"Cpf1 is a single RNA-guided endonuclease of a Class 2 CRISPR-Cas System.","volume":"163","author":"Zetsche","year":"2015","journal-title":"Cell"}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00838\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T04:33:00Z","timestamp":1597897980000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnins.2020.00838\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,20]]},"references-count":131,"alternative-id":["10.3389\/fnins.2020.00838"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2020.00838","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,20]]},"article-number":"838"}}